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SESSION II
PHARMACOECONOMIC & OUTCOMES
RESEARCH METHODOLOGY STUDIES—General
and Clinical Studies
PMD1
A NEW METHOD FOR TIME ADJUSTMENT OF
THE NUMBER NEEDED TO TREAT REGARDING
VARIABLE RELATIVE RISK REDUCTION
Aino H,Yanagisawa S, Cai L, Inoue H, Nakajo K, Kamae I
Kobe University, Kobe, Japan
Although the number needed to treat (NNT), a bench-
mark to describe an incremental effect between two
medical treatments, is potentially useful on pharmaco-
economics, the theoretical investigations still remain to
overcome its limitations such as time-constraint. At the
5th ISPOR European Congress, we presented a speciﬁc
solution for the time-constraint, assuming that relative
risk reduction (RRR) is constant at any time. The con-
stant-RRR model could adjust the NNT onto any point
over the time axis. OBJECTIVE: To cope with a more
practical case of assumptions, we theoretically develop 
a formula for time-adjustment of the NNT based on a
variable-RRR model. METHOD: A constant-RRR model
is expanded into a variable-RRR model, considering the
efﬁcacies of both experimental and control regimens in a
clinical trial. Suppose that both of them exponentially
increase, asymptotically converging to one, as the fol-
lowing-up duration goes to inﬁnity. Furthermore, we
investigate what the standardization of the NNT means
in the variable-RRR model. RESULTS: In contrast with
a constant-RRR model, in which the NNT monotonously
decreases as the following-up duration becomes longer,
the NNT function in a variable-RRR model indicated a
U-shaped curve against the monotony. That is, the curve
of the NNT function monotonously decreases until a
certain point of following-up time, whereas it mono-
tonously increases after that point as the time becomes
longer. It implies that there exists a unique minimal NNT
in a variable-RRR model. CONCLUSION: Although the
NNT with a unit duration of following-up time such as
one year is recommended as the standard in a constant-
RRR model, we found the NNT function has a unique
minimal value in a variable-RRR model, which is theo-
retically informative for standardization of the NNT.
Considering such features with different assumptions 
on relative risk reduction, we can employ the NNT to 
be integrated in time-dependent model of pharmaco-
economic analysis.
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OBJECTIVES: To review current approaches to effec-
tiveness research. Study was conducted in two Phases: 1)
a review of general methodological designs of effective-
ness research in published literature; and 2) a synopsis 
of outcomes measured in identiﬁed studies from selected
therapeutic areas. METHODS: A literature search was
completed using MEDLINE, EMBASE, and HEED
sources from January 1990 to July 2002 using pre-
determined keywords. Phase 1 of the study summarized
articles on general methodological designs of effectiveness
studies; their commonalities, advantages, and limitations.
Criteria to evaluate effectiveness studies based on these
ﬁndings were then established. Effectiveness studies from
pre-determined therapeutic areas that ﬁt these criteria
were then selected for Phase 2 and their outcome mea-
sures were summarized. RESULTS: Of the 306 articles
found, 16 publications were selected for Phase 1 and 35
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studies were selected for Phase 2. Results from Phase 1
identiﬁed a variety of methodological designs used,
ranging from retrospective database analyses to prospec-
tive simpliﬁed clinical trials. Each methodology had its
respective strengths and weaknesses. Although no “gold
standard” appeared to exist, there were several common
methodological attributes: 1) conducted in community
settings; 2) allowed ﬂexible regimens; 3) measured a wide
range of outcomes; and 4) monitored outcomes expected
in clinical practice. In Phase 2, the number of effective-
ness studies and the quality of the study designs in each
therapeutic area were highly variable. Certain therapeu-
tic areas had examples of well-designed effectiveness
studies, while others had either few studies, or the study
designs were lacking in rigor. CONCLUSIONS: There
was no evident standard methodology for conducting
effectiveness research in the literature. However, the
various outcomes measured in effectiveness studies can
provide useful evaluations of the potential beneﬁts that a
medical intervention may bring. It is the authors’ conclu-
sions that effectiveness studies with sound methodologi-
cal designs will provide valid and relevant information for
decision-making.
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INSTRUMENT STRENGTH AND PERFORMANCE
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OBJECTIVES: Testing the sensitivity of switching regres-
sion model’s estimator of ATE to the joint normality
assumption of error term distribution when there is selec-
tion bias; assessing the relationship between the sensitiv-
ity and the instrument strength. METHODS: We used the
Monte Carlo method to generate data with selection bias
under four different distributions: joint normal distribu-
tion, joint t distribution (df = 3), a joint right skewed dis-
tribution, and a joint symmetric two-peak distribution.
The parameters in the simulation were calibrated using
an asthma patient population selected from Medi-Cal 
eligibles between January 1995 and December 2000. The
simulated outcome variable can be considered as log-cost
or any continuous outcome variable in healthcare. We
varied the strength of the simulated instrumental variable.
For each instrument strength, 500 data sets were gener-
ated each with 1500 observations. We measured the 
sensitivity of switching regression model’s estimator of
ATE to the joint normality assumption in terms of root
mean square relative error (RMSRE) and relative bias.
RESULTS: For data simulated with error terms from all
of the four distributions, RMSRE of the ATE estimates
converge and decrease as instrument strength increases.
When the instrument strength equals 85%, the ATE esti-
mate for data simulated from the joint t error term dis-
tribution has the highest RMSRE at 48%, which is close
to the smallest RMSRE value at 40% for data simulated
from the joint normal distribution. The relative bias 
also converges as the instrument strength increases.
CONCLUSIONS: With a strong instrument, the para-
metric switching regression model was robust. This result
justiﬁes the use of the parametric switching regression
model to adjust for selection bias with a strong instru-
ment. The sensitivity of the switching regression model
with only weak instrument(s) results mostly from the lack
of information to identify the treatment effects, rather
than from the erroneous assumption of error term 
distribution.
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OBJECTIVES: Conditional expectation methods have
been widely used for their simplicity, and often without
adequate justiﬁcation. We tested the performance of treat-
ment effect estimators of two conditional expectation
methods: the linear outcome-equation model and a
propensity score method, under different levels of unob-
served selectivity. METHODS: We used the Monte Carlo
method to generate data with varied degree of unobserved
selectivity. The parameters in the simulation were cali-
brated using an asthma patient population selected from
Medi-Cal eligibles between January 1995 and December
2000. The simulated outcome variable can be considered
as log-cost, or any continuous outcome variable in health-
care. For each level of unobserved selectivity, 500 data
sets were generated each with 1500 observations. Both
the treatment effect in the general population (ATE) and
the treatment effect in the treated population (TT) were
estimated. Two conditional expectation methods, a linear
outcome-equation model and a propensity score method,
were applied to estimate treatment effects. The sensitiv-
ity of treatment effect estimators was measured using root
mean square relative error (RMSRE) and relative bias.
RESULTS: Our result showed that both conditional
expectation methods were sensitive to unobserved selec-
tivity. The relative bias of ATE estimate from the linear
outcome-equation model (propensity score method) was
greater than 50% when the combined unobserved selec-
tivity (treatment group and the control group) was greater
than 15% (8%). The result for RMSRE showed similar
level of sensitivity. The results also showed that a con-
sistent estimate of treatment effect on the treated (TT)
could be achieved under conditions less strict than those
required to achieve a consistent estimate of average treat-
ment effect (ATE). CONCLUSIONS: Our study shows
that the estimates from either conditional expectation
methods are acceptable only when there is no, or small,
